DAIKEN MEDICAL CO.,LTD (7775) Stock Price

Daiken Medical Instruments is a research and development-focused medical device manufacturer that designs, develops, manufactures, and sells products primarily related to anesthesia and hospital infection prevention. The company operates as an independent enterprise with no parent or subsidiary companies. Its core philosophy is to directly gather feedback from healthcare professionals and develop innovative products based on their actual needs.

The company's products are classified into five product categories. In the suction equipment category, it provides non-electric vacuum suction devices used in operating rooms and intensive care units. Major products include FitFix and Q-Pot, which feature disposable plastic containers designed from an infection prevention perspective.

In the infusion equipment category, it offers pressure-driven medical injectors designed to reduce post-operative pain. Key products include Syrinjecter, Balloon Jecter, PCA devices, and Amy. These devices operate without electricity and are designed with patient quality of life in mind.

In the electric pump category, it provides medical equipment that continuously administers precise micro-doses of medication. Main products include syringe pumps and infusion pumps, which are used in operating rooms and intensive care units. These devices enable highly accurate medication delivery.

In the hand hygiene equipment category, it provides facilities that support proper hand hygiene for healthcare workers. Major products include Steri-Keep II and Wipel, which supply sterile or disinfectant water and provide sterilized disposable towels.

Other product categories include Breath Warm, bronchial blocker tubes, double-lumen bronchial tubes, and disposable pulp systems. These products are designed for use in operating rooms and treatment rooms, providing patients and healthcare workers with hygienic and comfortable environments.

Daiken Medical is committed to opening new frontiers in healthcare by focusing on the development of innovative medical devices. The company develops products that directly reflect the needs of medical professionals and creates new value through proprietary technology. As a management principle, it aims to contribute to society by collaborating with healthcare workers to generate demand, particularly in anesthesia and operating room-related products.

As a medium to long-term growth strategy, Daiken Medical maintains integrated operations from research and development through manufacturing to sales, with rigorous quality management based on ISO standards. The company advances new product development with emphasis on innovation and safety, while expanding market share for existing products and strengthening entry into overseas markets. It specifically targets increased sales in price-competitive overseas markets and pursues expansion into new business areas.

The company uses gross profit margin and operating profit margin as key performance indicators, targeting an operating profit margin of 20%. In new product development, it continues investment for future growth without reducing research and development expenses, aiming to improve profitability. Through these efforts, the company seeks to enhance corporate value.

Daiken Medical prioritizes the expansion of existing products and development of new products to strengthen its leadership in the domestic market. It advances development of micropump-related products such as "Codetec Amy PCA," creating innovation in medical settings. This approach opens new markets and builds new business pillars.

Expansion in overseas markets is also a key strategy. Daiken Medical prioritizes entry into the European market and strengthens efforts to obtain MDR certification. The company aims to enhance international competitiveness by expanding its product lineup and sales network overseas.

The company also advances supply chain sophistication to reduce manufacturing costs. It pursues improved production efficiency and cost reduction while promoting optimization of production activities through data utilization. This enables flexible adaptation to changing business environments and sustainable growth.

Finally, the company strengthens recruitment of talented personnel and enhances education and training to improve corporate value. It actively pursues new graduate and mid-career hiring and revamps educational and training programs to increase competitiveness. Through improved employee compensation levels and implementation of efficient work practices, the company reinforces human capital investment.